| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA
2 Division of Space Life Sciences, NASA JSC, Universities Space Research Association, Houston, TX, USA
* To whom correspondence should be addressed. E-mail: brd{at}virginia.edu.
The glycocalyx (Gcx) is a complex and poorly understood structure covering the luminal surface of endothelial cells. It is known to be a determinant of vascular rheology and permeability, and may be a key site control site for the vascular injuries caused by ischemia/reperfusion. We used intravital-microscopy to evaluate the effects of ischemia/reperfusion injury (I/R-I) on two properties of Gcx in mouse cremasteric microvessels: exclusion of macromolecules (anionic-dextrans) and intracapillary distribution of red blood cells (RBC). In this model, the Gcx is rapidly modified by I/R-I, with an increase in 70 kDa anionic-dextran-penetration, without measurable effect on the penetration of 580 kDa anionic-dextran or on RBC-exclusion. The effects of I/R-I appear to be mediated by the rapid production of reactive-oxygen species (ROS), because they are ameliorated by the addition of exogenous SOD/Catalase. Intravenous application of allopurinol or heparin also inhibited the effects of I/R-I, and we interpret efficacy of allopurinol as evidence for a role for xanthine-oxidoreductase (XOR) in the response to I/R-I. Heparin, which is hypothesized to displace XOR from a heparin-binding domain in the Gcx, reduced the effects of I/R. The effects of I/R-I were also partially prevented or fully reversed by the intravascular infusion of exogenous hyaluronan. These data demonstrate: 1. The liability of Gcx during I/R-I, 2. The importance of locally produced ROS in the injury to Gcx, and 3. The potential importance of heparin-binding sites in modulating the ROS production. Our findings further highlight the relations between glycosaminoglycans and the pathophysiology of Gcx in vivo.
This article has been cited by other articles:
|
|
 |
|
  M. C. Meuwese, H. L. Mooij, M. Nieuwdorp, B. van Lith, R. Marck, H. Vink, J. J. P. Kastelein, and E. S. G. Stroes Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia J. Lipid Res., January 1, 2009; 50(1): 148 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Flessner Distributed model of peritoneal transport: implications of the endothelial glycocalyx Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2142 - 2146. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. G. E. VanTeeffelen, A. A. Constantinescu, J. Brands, J. A. E. Spaan, and H. Vink Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties J. Physiol., July 1, 2008; 586(13): 3207 - 3218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Haraldsson, J. Nystrom, and W. M. Deen Properties of the Glomerular Barrier and Mechanisms of Proteinuria Physiol Rev, April 1, 2008; 88(2): 451 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W.G.E. VanTeeffelen, J. Brands, C. Jansen, J. A.E. Spaan, and H. Vink Heparin Impairs Glycocalyx Barrier Properties and Attenuates Shear Dependent Vasodilation in Mice Hypertension, July 1, 2007; 50(1): 261 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. van den Berg and H. Vink Glycocalyx perturbation: cause or consequence of damage to the vasculature? Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2174 - H2175. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
